|
---|
Category:Legal-Exhibit
MONTHYEARML18058B0452018-02-0606 February 2018 Official Exhibit - NWMI-012-MA-CM01 - Northwest Medical Isotopes, LLC Responses to Commission'S Public Post-Hearing Questions ML18058B0462018-02-0606 February 2018 Official Exhibit - NRC-014-MA-CM01 - NRC Staff Responses to Commission Post-Hearing Questions (Feb. 6, 2018) ML18025B0992018-01-23023 January 2018 Official Exhibit - NWMI-004-R-MA-CM01 - Northwest Medical Isotopes, LLC Presentation Slides: Overview Presentation ML18025B1182018-01-16016 January 2018 Official Exhibit - NRC-004-MA-CM01 - NRC Staff Revised Responses to Commission Pre-Hearing Questions (Jan. 16, 2018) ML18025B0972018-01-16016 January 2018 Official Exhibit - NWMI-001-R-MA-CM01 - Northwest Medical Isotopes, LLC Responses to Commission'S Public Pre-Hearing Questions ML18025B0982018-01-16016 January 2018 Official Exhibit - NWMI-003-R-MA-CM01 - Statement of Qualifications in Support of Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Construction Permit Application ML18025B1002018-01-16016 January 2018 Official Exhibit - NWMI-005-R-MA-CM01 - Northwest Medical Isotopes, LLC Presentation Slides: Safety 1 Presentation ML18025B1042018-01-16016 January 2018 Official Exhibit - NWMI-006-R-MA-CM01 - Northwest Medical Isotopes, LLC Presentation Slides: Safety 2 Presentation ML18025B1062018-01-16016 January 2018 Official Exhibit - NWMI-007-R-MA-CM01 - Northwest Medical Isotopes, LLC Presentation Slides: Environmental Presentation ML18025B1082018-01-16016 January 2018 Official Exhibit - NWMI-011-R-MA-CM01 - Applicant'S Pre-Filed Testimony of Carolyn C. Haass for the Mandatory Hearing on Uncontested Issues for the Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility ML18025B1132018-01-16016 January 2018 Official Exhibit - NRC-002-MA-CM01 - Draft Construction Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (Revised Jan. 16, 2018) ML18025B1172018-01-16016 January 2018 Official Exhibit - NRC-003-MA-CM01 - Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov. 17, 2017) (Revised Jan. 16, 2018) ML18025B1212018-01-16016 January 2018 Official Exhibit - NRC-010-MA-CM01 - Staff Presentation Slides - Overview (Jan. 16, 2018) ML18025B1262018-01-16016 January 2018 Official Exhibit - NRC-012-MA-CM01 - Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018) ML18025B1292018-01-16016 January 2018 Official Exhibit - NRC-013-MA-CM01 - Staff Presentation Slides - Environmental Panel (Jan. 16, 2018) ML18025B1232018-01-16016 January 2018 Official Exhibit - NRC-011-MA-CM01 - Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018) ML18025B0902017-12-18018 December 2017 Official Exhibit - NWMI-010-MA-CM01 - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(f), Filing, for Northwest Medical Isotopes, LLC Radioisotope Production Facility, Dated December 18, 2017 ML18025B0872017-12-14014 December 2017 Official Exhibit - NWMI-008-MA-CM01 - Federal, State of Missouri, City of Columbia, and Boone County Letters of Support for the Construction and Operation of the Northwest Medical Isotopes, LLC Radioisotope Production Facility ML18025B1382017-11-30030 November 2017 Official Exhibit - NRC-008-MA-CM01 - Safety Evaluation Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017) (as Revised Jan. 2018) ML18025B1112017-11-16016 November 2017 Official Exhibit - NRC-001-MA-CM01 - SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) ML18025B1582017-09-30030 September 2017 Official Exhibit - NRC-006C-MA-CM01 - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) ML18025B1682017-09-30030 September 2017 Official Exhibit - NRC-006G-MA-CM01 - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 Through 18 (Sep. 2017) ML18025B1652017-09-30030 September 2017 Official Exhibit - NRC-006F-MA-CM01 - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 Through 12 (Sep. 2017) ML18025B1622017-09-30030 September 2017 Official Exhibit - NRC-006E-MA-CM01 - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 Through 10 (Sep. 2017) ML18025B1602017-09-30030 September 2017 Official Exhibit - NRC-006D-MA-CM01 - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) ML18025B1552017-09-30030 September 2017 Official Exhibit - NRC-006B-MA-CM01 - Northwest Medical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (Psar), NWMI-2013-021, Rev. 3, Chapters 1 Through 2 (Sep. 2017) ML18025B0892017-09-15015 September 2017 Official Exhibit - NWMI-009-MA-CM01 - Clean Water Act Section 401 Water Quality Certification of Northwest Medical Isotopes, LLC Facility in Boone County, NUREG-2209/CEK007189 ML18025B1402017-05-31031 May 2017 Official Exhibit - NRC-009-MA-CM01 - NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017) ML18025B1722015-06-30030 June 2015 Official Exhibit - NRC-006I-MA-CM01 - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. Oa, Chapter 19, 19-131 Through End (Jun. 2015) ML18025B1702015-06-30030 June 2015 Official Exhibit - NRC-006H-MA-CM01 - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. Oa, Chapter 19, Beginning Through 19-130 (Jun. 2015) ML18025B1542015-02-15015 February 2015 Official Exhibit - NRC-006A-MA-CM01 - Northwest Medical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) 2018-02-06
[Table view] |
Text
NRC-013 Northwest Medical Isotopes Construction Permit Application Review
- Mandatory Hearing (Environmental Panel)
- January 23, 2018 United States Nuclear Regulatory Commission Official Hearing Exhibit In the Matter of: NORTHWEST MEDICAL ISOTOPES, LLC (Medical Radioisotope Production Facility)
Commission Mandatory Hearing Docket #: 05000609 Exhibit #: NRC-013-MA-CM01 Identified: 1/23/2018 Admitted: 1/23/2018 Withdrawn:
Rejected: Stricken:
Other:
Panelists
- Chief, Environmental Review and NEPA Branch, NRR
- Physical Scientist, NRR
- Biologist, NRR
- Senior Project Manager, NRR 2 2
Environmental Review
- National Environmental Policy Act
- Environmental review process
- 10 CFR Part 51
- Interim Staff Guidance Augmenting NUREG-1537 for Licensing Radioisotope Production Facilities and Aqueous Homogenous Reactors 3
Scope of the Review: Proposed Action and Connected Actions Actions are connected if they:
- Automatically trigger other actions that may require environmental impact statements; or
- Cannot or will not proceed unless other actions are taken previously or simultaneously; or
- Are interdependent parts of a larger action and depend on the larger action for their justification 4
Proposed Action and Connected Actions
- Construction, operations, and decommissioning of the 10 CFR Part 50 production facility
- Construction, operations, and decommissioning related to target fabrication
- Transportation of targets to/from research reactors and irradiation of targets at research reactors 5
Environmental Impact Statement (EIS)
- Project-specific decision
- Operation of the proposed Northwest facility would include target fabrication and scrap recovery
- Environmental assessment might not support a finding of no significant impact 66
Scoping Process
- Eight comment letters or emails 77
Environmental Review Areas Air Quality Socioeconomics and Environmental Terrestrial Justice Resources Human Health Aquatic Resources Land Use Water Soils Resources Historic and Cultural Resources 8
Environmental Impacts Resource Area Impact Land Use and Visual Resources SMALL Air Quality and Noise SMALL Geologic Environment SMALL Ecological and Water Resources SMALL Historic and Cultural Resources SMALL Socioeconomics SMALL Human Health and Waste SMALL Transportation SMALL 9
Consultations Act Determination Endangered Species Act, No Effect Section 7 National Historic No Adverse Preservation Act, Effect Section 106 10
Alternatives
- Alternative technologies 11
Alternative Technologies
- Aqueous homogenous reactor
- Analyzed in depth
- Analyzed in depth 12
Costs and Benefits
- Inform recommendation to the Commission
- Environmental and financial
- Societal, medical, and economic 13
Draft Environmental Impact Statement
- Five comment letters or emails 14
Staff Conclusion and Recommendation
- Benefits (societal, medical, and economic) outweigh the costs (environmental, economic)
- Considered reasonable alternatives
- Recommend issuance of the construction permit 15
Future NEPA Analyses
- Application for an operating license
- License amendment requests from research reactors 16
Acronyms
- EIS - Environmental Impact Statement
- NEPA - National Environmental Policy Act
- NRR - Office of Nuclear Reactor Regulation 17